FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088639 [Registered on: 11/06/2025] Trial Registered Prospectively
Last Modified On: 17/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia
Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Implant placed in Non diabetic and controlled diabetic patient 
Scientific Title of Study   Correlation of crestal bone levels with expression of bone specific biomarkers around dental implants placed in Non Diabetic and Controlled Diabetic patients 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Soumya Parmar 
Designation  Post graduate student 
Affiliation  Institute of Dental Studies and Technologies 
Address  Department of Periodontology Institute of Dental Studies and Technologies Kadrabad Modinagar Ghaziabad Uttar Pradesh

Ghaziabad
UTTAR PRADESH
201201
India 
Phone  9078239715  
Fax    
Email  soumyaparmar0297@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manish Khatri 
Designation  Professor and HOD 
Affiliation  Institute of Dental Studies and Technologies 
Address  Department of Periodontology Institute of Dental Studies and Technologies Kadrabad Modinagar Ghaziabad Uttar Pradesh

Ghaziabad
UTTAR PRADESH
201201
India 
Phone  9810720335  
Fax    
Email  drmanishkhatri@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mansi Bansal 
Designation  Professor 
Affiliation  Institute of Dental Studies and Technologies 
Address  Department of Periodontology Institute of Dental Studies and Technologies Kadrabad Modinagar Ghaziabad Uttar Pradesh

Ghaziabad
UTTAR PRADESH
201201
India 
Phone  9871655313  
Fax    
Email  drmansibansal@gmail.com  
 
Source of Monetary or Material Support  
Institute of Dental Studies and Technologies Address: Room no 7,Department of Periodontology, NH-58, Delhi-Meerut Road,Kadrabad, Modinagar, Uttar Pradesh, India-201201 
 
Primary Sponsor  
Name  Institute of Dental Studies and Technologies 
Address  Room no 7, Department of Periodontology,NH-58,Delhi-Meerut Road,Kadrabad,Modinagar,Uttar Pradesh, India-201201 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSoumya Parmar  Institute of Dental studies and technologies  Room no 7, Department of Periodontology, 2nd floor
Ghaziabad
UTTAR PRADESH 
9078239715

soumyaparmar0297@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IDST Ethics Commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K056||Periodontal disease, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Implant in controlled diabetic patient.  Implant placement in controlled diabetic patients, HbA1c value levels less than 6.9 
Comparator Agent  Implant placement in systemically healthy patient  Implant supported oral rehabilatation has increasingly improved the treatment options for edentulous patient reporting high long term survival and success rate 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Good oral hygiene
systemically healthy
Controlled diabetic
minimum two or even multiple number of missing teeth with sufficient bone length and width along with adequate inter-occlusal clearance. 
 
ExclusionCriteria 
Details  Patients will be excluded if they are smokers or have para-functional habits, uncontrolled diabetes, blood disorders, immune-compromised state, and acute infection at site or aggressive periodontal disease. Patients on bisphosphonates, pregnant and lactating women will also be excluded from the study. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
mesial and distal crestal bone level
probing depth at four sites

alkaline phosphatase and c terminal collagen propetide serum evaluation increase or decrease in experimental & control group 
crestal bone level at baseline, 3 month,6 month

alkaline phosphatase and c terminal collagen propeptide evaluation at baseline, 3 month and 6 month  
 
Secondary Outcome  
Outcome  TimePoints 
Modified plaque index (mPI).
Simplified gingival index (sGI).
Modified sulcular bleeding index (mSBI)

 
Baseline(at the time of crown placement), 3 months
probing depths at four sites (mesiobuccal, mid-buccal, distobuccal and mid-palatal/lingual)
 
 
Target Sample Size   Total Sample Size="24"
Sample Size from India="24" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/06/2025 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="3"
Days="10" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
This study will be conducted and compiled by Dr. Soumya Parmar, Dr Manish Khatri, Dr. Mansi Bansal, Dr. Sakshi Gaind at Department of Periodontology, Institute of Dental Studies and Technologies, modinagar,Uttar pradesh,India.The purpose of the study to evaluate the crestal bone level with expression of bone specific serum biomarkers [alkaline phosphatase (ALP) and C- terminal collagen propeptide (CICP)] around dental implants placed in non-diabetic and controlled diabetic patients. 
Close